KR920702344A - 과산화산 클라드레트, 그것의 제조방법 및 사용방법 - Google Patents

과산화산 클라드레트, 그것의 제조방법 및 사용방법

Info

Publication number
KR920702344A
KR920702344A KR1019920700695A KR920700695A KR920702344A KR 920702344 A KR920702344 A KR 920702344A KR 1019920700695 A KR1019920700695 A KR 1019920700695A KR 920700695 A KR920700695 A KR 920700695A KR 920702344 A KR920702344 A KR 920702344A
Authority
KR
South Korea
Prior art keywords
peroxide
derivative
acid
cyclodextrin
water
Prior art date
Application number
KR1019920700695A
Other languages
English (en)
Inventor
미쉘 그랑제르
미쉘 듀퐁
앙리 레동
Original Assignee
마르크 부스타레
케목살 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마르크 부스타레, 케목살 에스.에이. filed Critical 마르크 부스타레
Publication of KR920702344A publication Critical patent/KR920702344A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0039—Coated compositions or coated components in the compositions, (micro)capsules
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C409/00—Peroxy compounds
    • C07C409/24—Peroxy compounds the —O—O— group being bound between a >C=O group and hydrogen, i.e. peroxy acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C409/00—Peroxy compounds
    • C07C409/24—Peroxy compounds the —O—O— group being bound between a >C=O group and hydrogen, i.e. peroxy acids
    • C07C409/26—Peracetic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C409/00—Peroxy compounds
    • C07C409/24—Peroxy compounds the —O—O— group being bound between a >C=O group and hydrogen, i.e. peroxy acids
    • C07C409/30—Peroxy compounds the —O—O— group being bound between a >C=O group and hydrogen, i.e. peroxy acids a >C=O group being bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/39—Organic or inorganic per-compounds
    • C11D3/3945—Organic per-compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Materials Engineering (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Polymers & Plastics (AREA)
  • Environmental Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

과산화산 클라드레트, 그것의 제조방법 및 사용방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (16)

  1. 소정의 과산화산에 대해 수용구조의 작용할 수 있는 중공분자에 내포되어 있는 화합물 또는 클라드레트인 것을 특징으로 하는 과산화산의 유도체.
  2. 제1항에 있어서, 상기 수용구조로서 작용하는 분자가 시클로덱스트린의 구조, 예를 들면 α-시클로덱스트린, β-시클로덱스트린, r-시클로덱스트린 또는 시클로덱스트린 유도체의 구조를 갖는 것을 특징으로 하는 과산화산의 유도체.
  3. 제1항 또는 제2항에 있어서, 과산화산이, -R1-CO3H 구조의 일과산화산, -HO3C-R2-CO3H 구조의 이과산화산 중에서 선택되며, 여기에서 R1은 알킬, 아릴, 시클로알킬기를 가리키고, R2는 알킬렌, 아릴렌, 시클로알킬렌기를 가리키며, R1과 R2는 작용기, 구체적으로 에스테르나 아미드 형태의 한개 또는 그 이상의 카르복실작용기, 예를들면 알칼리금속염, 알칼리토금속염, 암모늄염 또는 포스포늄염 등의 염, 및/또는 될 수 있는 한 한개 또는 그 이상의 고리, 아미노, 알킬아미노, 아실아미노, 아실, 니트릴, 니트로, 트리플루오로메틸, 술포닐을 지니는 한개 또는 그 이상의 알킬, 알콕시, 아릴기, 및/또는 한개 또는 그 이상의 할로겐 원자에 의해 임의로 치환된 것을 특징으로 하는 과산화산의 유도체.
  4. 제3항에 있어서, 상기 알킬 또는 알킬렌 라디칼이 1 내지 12개의 탄소 원자로 이루어져 있고, 상기 아릴라디칼은 페닐 라디칼이며, 상기 아릴렌 라디칼은 페닐렌 라디칼인 것을 특징으로하는 과한화산의 유도체.
  5. 제1항 내지 제4항중 어느 한 항에 있어서, 클라드레트 제조에 사용된 과산화산이 과산화산과 이에 상당하는 수몰 % 내지 약 90몰%, 보다 구체적으로는 약 10 내지 40% 분량의 유기산을 혼합한 것이며, 실온에서 고체인 과산화산은 그 함량이 적어도 약 80중량%인 혼합물의 형태를 취하는 것을 특징으로 하는 과산화산의 유도체.
  6. 순수한 과산화산 또는 과산화산 혼합물을 상기 과산화산에 대한 수용구조로서 작용하기에 적합한 화합물에 첨가하는 단계 및 형성된 클라드레트를 회수하는 단계를 포함하는 제1항에 의한 과산화산의 유도체의 제조방법.
  7. 제6항에 있어서, 실온에서 고체인 과산화산을 적합한 용매-예를들면 물 또는 물/알코올 등의 수용성 혼합 용매를 사용하여 용액상태를 만들고, 이 용액을 용액중에 존재하는 수용구조 화합물에 첨가하며, 1 내지 6개의 탄소 원자를 포함하는 알킬 과산화산과 같은 수용성 과산화산은 이에 상당하는 카르복실산과 과산화수소로 이루어진 혼합물 형태이며, 황산이나 인산 또는 술폰산과 같은 무기상산 등의 촉매를 상기 혼합물에 첨가하는 것을 특징으로 하는 방법.
  8. 제7항에 있어서, 상기 과산화산 용액이 디피콜린산과 같은 안정화제를 포함하는 것을 특징으로 하는 방법.
  9. 제1항 내지 제5항중 어느 한 항에 있어서, 적어도 하나의 과산화산 유도체와 임의의 불활성 부형제를 포함하는 것을 특징으로 하는 표백제.
  10. 제1항 내지 제5항중 어느 한 항에 있어서, 적어도 하나의 과산화산 유도체와 임의의 불활성 부형제를 포함하는 것을 특징으로 하는 소독제.
  11. 제1항 내지 제5항중 어느 한 항에 있어서, 적어도 하나의 과산화산 유도체와 임의의 불활성 부형제를 포함하는 것을 특징으로 하는 미용제.
  12. 제1항 내지 제5항중 어느 한 항에 있어서, 적어도 하나의 과산화산 유도체와 임의의 불활성 부형제를 포함하는 것을 특징으로 하는 신체 위생용 약품.
  13. 활성성분으로서, 제1항 내지 제5항중 어느 한항에 의한 적어도 하나의 과산화산 유도체를 포함하는 약제.
  14. 방부 활성을 지닌, 예를들면 소화관, 피부, 점막 또는 생식 기관의 감염에 대항하는, 약제를 제조하는데 제1항 내지 제5항중 어느 한 항에 의한 과산화산 유도체를 사용하는 방법.
  15. 제9항 내지 제14항중 어느 한 항에 있어서, 임의의 불활성 부형제와 결합되어 있는, 분말, 정체 또는 과립의 형태인 것을 특징으로 하는 약품 또는 약제.
  16. 유기 합성시의 반응물로서 제1항 내지 제5항중 어느 한 항에 의한 과산화산 유도체를 사용하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920700695A 1990-07-30 1991-07-30 과산화산 클라드레트, 그것의 제조방법 및 사용방법 KR920702344A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR90/09677 1990-07-30
FR9009677A FR2665158B1 (fr) 1990-07-30 1990-07-30 Clathrates de peroxyacides.
PCT/FR1991/000628 WO1992002497A1 (fr) 1990-07-30 1991-07-30 Clathrates de peroxyacides, leur preparation et leurs utilisations

Publications (1)

Publication Number Publication Date
KR920702344A true KR920702344A (ko) 1992-09-03

Family

ID=9399210

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920700695A KR920702344A (ko) 1990-07-30 1991-07-30 과산화산 클라드레트, 그것의 제조방법 및 사용방법

Country Status (17)

Country Link
US (1) US5382571A (ko)
EP (1) EP0469983B1 (ko)
JP (1) JPH05502890A (ko)
KR (1) KR920702344A (ko)
AT (1) ATE118764T1 (ko)
AU (1) AU653545B2 (ko)
BR (1) BR9105822A (ko)
CA (1) CA2066050A1 (ko)
DE (1) DE69107547T2 (ko)
DK (1) DK0469983T3 (ko)
ES (1) ES2068535T3 (ko)
FR (1) FR2665158B1 (ko)
GR (1) GR3015160T3 (ko)
MX (1) MX174656B (ko)
NO (1) NO921172L (ko)
PT (1) PT98481B (ko)
WO (1) WO1992002497A1 (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19512588A1 (de) * 1995-04-04 1996-10-10 Bode Chemie Gmbh & Co Mittel zur Instrumentendesinfektion
DE19724102A1 (de) * 1997-06-07 1998-12-10 Bode Chemie Gmbh & Co Mittel zur Schnelldekontamination und -desinfektion von Haut und Händen
IT1293820B1 (it) * 1997-08-05 1999-03-10 Ausimont Spa Composizioni a base di perossiacidi
US6261540B1 (en) * 1997-10-22 2001-07-17 Warner-Lambert Company Cyclodextrins and hydrogen peroxide in dental products
WO2000012828A1 (fr) * 1998-09-01 2000-03-09 Nippon Soda Co., Ltd. Separateur de boues et agent de prevention et d'elimination des boues
US6569824B2 (en) * 2000-02-16 2003-05-27 Novartis Ag Contact lens treating method and composition
SK282717B6 (sk) * 2000-03-10 2002-11-06 �Stav Experiment�Lnej Farmakol�Gie Sav Spôsob prípravy ultravysokomolekulových hyalurónanov
DE602006013778D1 (de) * 2006-01-23 2010-06-02 Procter & Gamble Zusammensetzung enthaltend vorgeformte Persäure und einen Bleichmittelkatalysator
US8809392B2 (en) 2008-03-28 2014-08-19 Ecolab Usa Inc. Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents
US8871807B2 (en) 2008-03-28 2014-10-28 Ecolab Usa Inc. Detergents capable of cleaning, bleaching, sanitizing and/or disinfecting textiles including sulfoperoxycarboxylic acids
AU2009230713C1 (en) 2008-03-28 2018-08-02 Ecolab Inc. Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents
US9321664B2 (en) 2011-12-20 2016-04-26 Ecolab Usa Inc. Stable percarboxylic acid compositions and uses thereof
BR112014020748B1 (pt) 2012-03-30 2021-02-23 Ecolab Usa Inc. método de tratamento de águas, método de tratamento de uma fonte de água e composição aquosa de tratamento de água com atividade antimicrobiana
US8871186B2 (en) 2012-08-21 2014-10-28 Red Lion Chem Tech, Llc Compositions and methods for control of malodor and other environmental contaminants
US20140256811A1 (en) * 2013-03-05 2014-09-11 Ecolab Usa Inc. Efficient stabilizer in controlling self accelerated decomposition temperature of peroxycarboxylic acid compositions with mineral acids
EP3300714A1 (en) * 2016-09-30 2018-04-04 DENTSPLY DETREY GmbH Dental composition
EP3536303A1 (en) * 2018-03-07 2019-09-11 Dentsply DeTrey GmbH Dental composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153630A (en) * 1975-10-22 1979-05-08 Teijin Limited Inclusion compounds, process for preparation thereof, and process for separating isomers using the inclusion compounds
JPS55122709A (en) * 1979-03-13 1980-09-20 Asama Kasei Kk Stench remover from mouth
US4540721A (en) * 1983-03-10 1985-09-10 The Procter & Gamble Company Method of providing odor to product container
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
FR2596617B1 (fr) * 1986-04-08 1990-10-05 Orstom Composition a base d'acide gras complexe par des cyclodextrines, son procede de preparation et application phytosanitaire
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US5102564A (en) * 1989-04-12 1992-04-07 The Procter & Gamble Company Treatment of fabric with perfume/cyclodextrin complexes
US5094761A (en) * 1989-04-12 1992-03-10 The Procter & Gamble Company Treatment of fabric with perfume/cyclodextrin complexes
JPH0366665A (ja) * 1989-08-04 1991-03-22 I C S Kk 包接化合物
DE4010531A1 (de) * 1990-04-02 1991-10-10 Thomae Gmbh Dr K Cyclophane, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
JP2700164B2 (ja) * 1991-03-01 1998-01-19 株式会社スノーヴァ 氷床および人工雪の製造方法

Also Published As

Publication number Publication date
NO921172D0 (no) 1992-03-26
CA2066050A1 (fr) 1992-01-31
ATE118764T1 (de) 1995-03-15
AU8320191A (en) 1992-03-02
DE69107547T2 (de) 1995-10-05
MX174656B (es) 1994-05-31
DK0469983T3 (da) 1995-05-08
EP0469983B1 (fr) 1995-02-22
GR3015160T3 (en) 1995-05-31
EP0469983A1 (fr) 1992-02-05
JPH05502890A (ja) 1993-05-20
PT98481B (pt) 1997-12-31
FR2665158B1 (fr) 1993-12-24
DE69107547D1 (de) 1995-03-30
WO1992002497A1 (fr) 1992-02-20
FR2665158A1 (fr) 1992-01-31
NO921172L (no) 1992-05-29
AU653545B2 (en) 1994-10-06
PT98481A (pt) 1992-05-29
US5382571A (en) 1995-01-17
BR9105822A (pt) 1992-09-22
ES2068535T3 (es) 1995-04-16
MX9100448A (es) 1992-07-01

Similar Documents

Publication Publication Date Title
KR920702344A (ko) 과산화산 클라드레트, 그것의 제조방법 및 사용방법
RU2085191C1 (ru) Жидкая антибактериальная композиция
KR860009032A (ko) γ-사이클로 덱스트린 유도체의 제조방법
AR031828A2 (es) Procedimientos para la preparacion de compuestos espiro-azabiciclicos utiles en terapia
DE69024503D1 (de) Antikorrosive mikrobizide
ES2053587T3 (es) Nuevos derivados de bencimidazoles activos como agentes anti-ulcera.
PE18595A1 (es) Sintesis asimetrica
KR880003626A (ko) 레트로비루스로 감염된 환자의 치료에 있어서의 2',3'-디디옥시사이티딘-2'-엔(2',3'-디디옥시-2',3'-디디하이드로사이티딘)의 사용법
ATE13765T1 (de) 2-(1,4-benzodioxan-2-ylalkyl)-imidazole, deren herstellung und sie enthaltende pharmazeutische mittel.
KR960031442A (ko) 페닐시클로헥실카르복스아미드의 용도
GB1245524A (en) Benzomorpholine coupling agents
ATE27270T1 (de) Thioester von acetylsalicylsaeure, ein verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE34662T1 (de) Derivate der benzoesaeure, herstellungsverfahren und anwendung in desinfizierenden und konservierenden arzneimitteln.
KR870004967A (ko) 무정형 벤즈 이미다졸 유도체
PL121664B1 (en) Process for preparing inclusion compounds of prostacycline and its esters with alkyls of 1 to 4 carbon atoms with cyclodextrinsna i ego alkilovykh ehfirov s 1-4 atomami uglja s ciklogekstrinami
KR930023338A (ko) 데포우 제제
DK0574355T3 (da) Phosphinyloxypropanaminium-indre saltderivater
KR900016143A (ko) 항매제인 디클로로-치환 이미다졸 유도체
IL44837A (en) Trialcaoxybenzoylamino acids - carboxyls containing sulfur, their preparation and distillates containing them
ATE26271T1 (de) Benzhydrylpiperazine-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE19981795T1 (de) Tilidinmesylat, Verfahren zu dessen Herstellung und pharmazeutische Zusammensetzung davon
KR930019672A (ko) 치환된 이미다졸 유도체 및 그의 제조방법
NO823682L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridazinonimin-derivater.
TH9830A (th) อนุพันธ์ต่างๆ ของพิร์โรโล (2, 1 - b) ไธอะโซล
ES2036722T3 (es) Un procedimiento para preparar una composicion farmaceutica que contiene un agente estabilizador.

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee